Welcome to LookChem.com Sign In|Join Free
  • or
2-((4R,4aS,7R,7aR,12bS,13S)-9-(benzyloxy)-3-(cyclopropylmethyl)-4a,13-dihydroxy-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl)isoindoline-1,3-dione is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

936833-87-3

Post Buying Request

936833-87-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

936833-87-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 936833-87-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,6,8,3 and 3 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 936833-87:
(8*9)+(7*3)+(6*6)+(5*8)+(4*3)+(3*3)+(2*8)+(1*7)=213
213 % 10 = 3
So 936833-87-3 is a valid CAS Registry Number.

936833-87-3Downstream Products

936833-87-3Relevant academic research and scientific papers

Discovery of highly selective κ-opioid receptor agonists: 10α-Hydroxy TRK-820 derivatives

Suzuki, Shinya,Sugawara, Yuji,Tsuji, Riichiro,Tanimura, Ryuji,Kaneko, Chihiro,Yuzawa, Natsumi,Yagi, Mai,Kawai, Koji

, p. 3920 - 3924 (2017)

κ-Opioid receptor agonists with high selectivity over the μ-opioid receptor are attractive targets in the development of drugs for pain and pruritus. We previously reported the synthesis of 10α-hydroxy TRK-820 (1). In this study, we elucidated the biologi

MORPHINAN DERIVATIVE AND A PHARMACEUTICAL USE THEREOF

-

, (2018/05/05)

PROBLEM TO BE SOLVED: To provide a compound having peripheral, selective opioid κ receptor agonistic action. SOLUTION: The present invention provides a morphinan derivative represented by the following formula (I) or formula (II), or a pharmacologically a

THERAPEUTIC OR PROPHYLACTIC AGENT FOR FUNCTIONAL BOWEL DISORDER

-

Page/Page column 26, (2008/12/07)

A therapeutic or prophylactic agent for functional bowel disorders comprising as an effective ingredient a morphinan derivative having a nitrogen-containing cyclic group or a pharmaceutically acceptable acid addition salt thereof is disclosed. The therapeutic or prophylactic agent for functional bowel disorders comprises as an effective ingredient a morphinan derivative or a pharmaceutically acceptable acid addition salt thereof, having a specific structure, such as N-(17-cyclopeopylmethyl-4,5α-epoxy-3,14-dihydroxy-morphinan-6β-yl)-3,4,5,6-tetrahydrophthalimide tartaric acid salt (Compound 10).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 936833-87-3